National Institute on Drug Abuse; Notice of Closed Meeting, 55375-55376 [2018-24100]
Download as PDF
<![CDATA[
55375
Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices
other than their time. The total
estimated annualized burden hours are
13,297.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Number of
responses per
respondent
Average time/
response
(hours)
Total annual
burden hours
High School Scientific Training & Enrichment Program—Orientation .............
High School Scientific Training & Enrichment Program 2.0—Orientation ......
HiSTEP & HiSTEP2—Alumni Tracking ...........................................................
Summer Internship Program—Application ......................................................
Summer Internship Program—Recommendation Letters ................................
Amgen Scholars at NIH—Supplemental Application .......................................
Amgen Scholars at NIH—Feedback ................................................................
Amgen Scholars at NIH—Alumni Tracking .....................................................
Community College Summer Enrichment Program—Alumni Tracking ...........
College—Summer Opportunities in Advanced Research—Alumni Tracking ..
Graduate—Summer Opportunities in Advanced Research—Alumni Tracking
Graduate Data Science Summer Program—Alumni Tracking ........................
Native American Visit Week—Application .......................................................
Native American Visit Week—Recommendation Letters ................................
Native American Visit Week—Feedback .........................................................
Undergraduate Scholarship Program—Application .........................................
Undergraduate Scholarship Program—Recommendation Letters for Applicants .............................................................................................................
Undergraduate Scholarship Program—Exceptional Financial Need—Completed by Applicant .......................................................................................
Undergraduate Scholarship Program—Exceptional Financial Need—Completed by University Staff .............................................................................
Undergraduate Scholarship Program—Exceptional Financial Need Resubmission—Completed by Applicant ...............................................................
Undergraduate Scholarship Program—Exceptional Financial Need Resubmission—Completed by University Staff ......................................................
Undergraduate Scholarship Program—Scholar Contract ................................
Undergraduate Scholarship Program—Evaluation of Scholar Pay Back Period ...............................................................................................................
Undergraduate Scholarship Program—Renewal Application ..........................
Undergraduate Scholarship Program—Recommendation Letters for Renewals .................................................................................................................
Undergraduate Scholarship Program—Deferment Form—Completed by
Scholar .........................................................................................................
Undergraduate Scholarship Program—Deferment Form—Completed by University Staff ..................................................................................................
Postbaccalaureate Training Program—Application .........................................
Postbaccalaureate Training Program—Recommendation Letters ..................
NIH Academy—Fellow & Certificate Programs Application ............................
NIH Academy—Enrichment Program Application ...........................................
Graduate Partnerships Program—Application .................................................
Graduate Partnerships Program—Recommendation Letters for Application ..
Graduate Partnerships Program—Interview Experience Survey ....................
Graduate Partnerships Program—Registration ...............................................
Graduate Partnerships Program—Awards Certificate .....................................
MyOITE—User Accounts .................................................................................
MyOITE—NIH Alumni ......................................................................................
OITE Careers Blog—Success Stories .............................................................
25
25
125
8,000
16,000
535
20
127
158
158
114
30
15
15
15
125
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
10/60
10/60
30/60
45/60
10/60
10/60
15/60
30/60
10/60
10/60
30/60
30/60
20/60
10/60
15/60
60/60
4
4
125
6,000
2,667
89
5
64
26
26
57
15
5
3
4
125
375
1
10/60
63
125
1
3/60
8
125
1
15/60
41
38
1
3/60
8
38
25
1
1
15/60
10/60
41
4
30
15
1
1
15/60
45/60
8
11
15
1
10/60
3
10
1
3/60
1
10
2,250
6,750
300
175
325
975
30
175
75
6,000
500
6
1
1
1
1
1
1
1
1
1
1
1
1
1
12/60
45/60
10/60
15/60
15/60
60/60
10/60
10/60
15/60
30/60
3/60
15/60
45/60
2
1,688
1,125
75
44
325
163
5
44
38
300
125
5
Totals ........................................................................................................
43,854
43,979
N/A
13,297
Dated: October 29, 2018.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2018–24150 Filed 11–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
18:38 Nov 02, 2018
Jkt 247001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
E:\FR\FM\05NON1.SGM
05NON1
55376
Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Quantification of Drugs of Abuse and Related
Compounds in Biological Specimens (8951).
Date: December 6, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–24100 Filed 11–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK SEP: RC2.
Date: November 19, 2018.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call)
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
VerDate Sep<11>2014
18:38 Nov 02, 2018
Jkt 247001
Room 7009, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–4721,
Kozelp@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: October 30, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–24098 Filed 11–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee to
the Director, National Institutes of
Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 13, 2018.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: NIH Director’s Report, ACD
Working Group Reports, Other Business of
the Committee.
Place: National Institutes of Health.
Building 31, 6th Floor Conference Room 6C,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, Woodgs@od.nih.gov.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 14, 2018.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: ACD Working Group Reports,
Other Business of the Committee.
Place: National Institutes of Health,
Building 31, 6th Floor Conference Room 6C,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, Woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–24097 Filed 11–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Cardiovascular Disease.
Date: November 13, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 83, Number 214 (Monday, November 5, 2018)]
[Notices]
[Pages 55375-55376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which
[[Page 55376]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Quantification of Drugs of Abuse and Related
Compounds in Biological Specimens (8951).
Date: December 6, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24100 Filed 11-2-18; 8:45 am]
BILLING CODE 4140-01-P
